TRWD Reserves “ARC Entertainment Group” Name to Anchor Its Multi-Brand Platform
ARCPOINT ANNOUNCES APPOINTMENT OF PETER KENDALL AS INTERIM CHIEF EXECUTIVE OFFICER
Can GlobalFoundries' ARC Acquisition Strengthen Its Physical AI Push?
Exclusive distribution agreement marks Nanox's entry into the Peruvian market
ARC Group Acquisition I Corp Announces the Separate Trading of its Ordinary Shares, Warrants and Rights
Nanox Announces Distribution Agreement with NuvioDx to Support Deployment of Nanox.ARC Systems
ARC Group Acquisition I Corp Announces Closing of $120,750,000 Initial Public Offering
ARC Group Acquisition I Corp Announces Pricing of $105,000,000 Initial Public Offering
ARCPOINT ANNOUNCES RESIGNATION OF BOARD MEMBER
Nanox.ARC X Digital Advanced 3D imaging built for access and powered by innovation Wins 2026 Red Dot Award for Product Design
Nanox Signs Distribution Agreement with Digital X-Ray Imaging to Expand Nanox.ARC Adoption in Arkansas
ARC Resources: Still Not Noticed By The Market
Nanox Signs Distribution Agreement with Integrity Medical Service, Inc. to Deploy Nanox.ARC Systems
Nanox Signs Distribution Agreement with Imperial Imaging Technology to Expand Nanox.ARC Access Across U.S. Southeast
ARC Resources: One Of Canada's Best Energy Plays That's Still Undervalued
Nanox Expands in Latin America with Exclusive Nanox.ARC Distribution Agreement in Argentina
Nanox to Showcase Nanox.ARC Live in Europe for First Time and Present New AI Capabilities at ECR 2026
ARC Resources: When The Market And Logic Part Ways
Nanox Receives FDA 510(k) Clearance for TAP2D New Image Enhancement Capability for Nanox.ARC and Nanox.ARC X Systems
Nanox Expands in Europe with New Nanox.ARC Distribution Engagement in Serbia, Montenegro, and Bosnia and Herzegovina
Ruanyun Edai Technology Inc. Establishes $100 Million Equity Purchase Facility with ARC Group International to Enhance Financial Flexibility
ARC Energy Fund 8 Completes Take-Private Acquisition of STEP Energy Services Ltd.
ARC Resources: The Growth Plan Remains In Place
ARC Resources: Buy The Dip
Nanox Engages with Althea France to Accelerate European Commercialization of Nanox.ARC System
ScanTech AI Systems Signs Term Sheet for $20 Million Financing with ARC Group to Enhance Liquidity and Strategic Flexibility
ARC at Sheba Medical Center and Mount Sinai Launch Collaboration with NVIDIA to Crack the Hidden Code of the Human Genome Through AI
ONWARD Medical Receives FDA 510(k) Clearance Expanding ARC-EX System Indication for Home Use
Nanox to Launch FDA-Cleared Nanox.ARC X and Present development of new AI innovations at RSNA 2025 Annual Meeting
ARC Resources: Understanding The 9% Decline And What It Means For Investors
ARC Resources: Earnings Are On Track
Beam Middle East to Introduce EV ARC™ and BeamBike™ at DRIFTx in Abu Dhabi
ONWARD Medical Provides Preliminary Q3 2025 Update Highlighting Accelerating ARC-EX Adoption in the United States
ARC Group Invests in ScanTech AI Systems, Backing Company's AI-Powered Security and Regulatory Alignment
Concurrent Publications in Nature and Nature Medicine Highlight Advances in Blood Pressure Regulation after Spinal Cord Injury Using ONWARD ARC-IM Therapy
ONWARD Medical Receives CE Mark for ARC-EX, Enabling Commercial Launch of Breakthrough Spinal Cord Stimulation System in Europe
ONWARD Medical Receives FDA IDE Approval to Initiate the Empower BP Pivotal Study with the ARC-IM System
Arc Resources: Look Beyond 2028 At This Undervalued Cannibal
Descartes Named Top Provider of Cloud-based TMS Solutions and Top Fleet Management Provider in ARC Advisory Group's Transportation Management Systems Global Report
Hana RFID Introduces The ‘Brava', an Ultra-Compact (42x16) ARC-Certified Inlay equipped with Impinj M830 chip
ARC Resources: An Extra Production Jump From An Acquisition
Nanox Announces Clinical and Educational Collaboration with Keiser University Featuring the Nanox.ARC
ONWARD Medical Files 510(k) with US FDA for ARC-EX System Home Use and Submits CE Mark Application
ONWARD Medical Builds Commercial Momentum for the ARC-EX System and Reinforces its Brain-Computer Interface Leadership in Q1 2025
Initial Data from the ARC-20 Study of Casdatifan Plus Cabozantinib Showed Nearly Half of Patients with Metastatic Kidney Cancer Had a Confirmed Response
ARC Resources: Double First Quarter Boost Thanks To The Attachie Project
ONWARD Medical Announces First-in-Human Use of ARC-IM Lumbar Lead Designed to Restore Standing, Stepping, and Lower Limb Mobility
METAVISIO – THOMSON Computing : ARC Group launches Phase 2 of the U.S. Listing Process